Biogen, Inc. (NASDAQ: BIIB) Q4 2020 earnings call dated Feb. 03, 2021
Corporate Participants:
Mike Hencke — Director, Investor Relations
Michel Vounatsos — Chief Executive Officer
Alfred W. Sandrock — Executive Vice President
Michael McDonnell — Executive Vice President Chief Financial Officer
Analysts:
Max Skor — Morgan Stanley — Analyst
Terence Flynn — Goldman Sachs — Analyst
Marc Goodman — SVB Leerink — Analyst
Umer Raffat — Evercore — Analyst
Cory Kasimov — JPMorgan — Analyst
Evan Seigerman — Credit Suisse — Analyst
Michael Yee — Jefferies — Analyst
Paul Matteis — Stifel — Analyst
Phil Nadeau — Cowen & Company — Analyst
Jay Olson — Oppenheimer — Analyst
Robyn Karnauskas — Truist — Analyst
Salim Syed — Mizuho — Analyst
_________
To read the full earnings call transcript, click here
Most Popular
ACN Earnings: All you need to know about Accenture’s Q2 2023 earnings results
Accenture (NYSE: ACN) reported second quarter 2023 earnings results today. Total revenues increased 5% year-over-year to $15.8 billion. Net income attributable to Accenture plc was $1.52 billion, or $2.39 per
Here’s how FedEx (FDX) plans to soften the impact of volume declines on its business
Shares of FedEx Corporation (NYSE: FDX) stayed green on Wednesday. The stock has gained 26% year-to-date. The company faced a challenging environment in the third quarter of 2023 which took
Walgreens Boots Alliance (WBA) shifts to expansion mode. Will it pay off?
Walgreens Boots Alliance, Inc. (NASDAQ: WBA), a market leader in retail pharmacy, has regularly revised its business model to better align with the transformation the healthcare space is witnessing. Currently,
Listen On
